Literature DB >> 16020930

Stress symptoms induced by repeated morphine withdrawal in comparison to other chronic stress models in mice.

Dóra Zelena1, István Barna, Martin Mlynarik, O P Gupta, Daniela Jezova, Gábor B Makara.   

Abstract

The present study was aimed at evaluating chronic stress models in mice with special attention to morphine treatment. We hypothesized that repeated periods of drug withdrawal induce chronic stress. To verify this hypothesis, mice were made dependent on morphine and then subjected to several types of repeated withdrawal. Body weight reduction, thymus involution, adrenal gland enlargement and activation of the hypothalamo-pituitary-adrenal axis were used as signs of chronic stress. The changes were compared to those induced by 'laboratory' models of chronic stress (2 weeks of repeated restraint or rat exposure) and to a disease model of streptozotocin-induced diabetes mellitus (STZ-DM). Mice were made dependent using increasing doses of morphine three times a day for 3 days (10-20-40 mg/kg s.c.). Thereafter, withdrawal was induced either spontaneously (morphine 40 mg/kg injected at 24- or 72-hour time intervals for 2 weeks) or repeatedly precipitated by naloxone (10 mg/kg s.c.) injected daily 3 h after morphine. The results show that repeated periods of spontaneous drug withdrawal (24 or 72 h) in morphine-dependent mice represent a mild stress load. Repeated withdrawal precipitated by naloxone induced clear chronic stress-like changes. Changes observed in the naloxone-precipitated withdrawal model were even more pronounced than those found in laboratory models, namely repeated restraint or exposure to the rat. The most severe chronic stress state developed in mice during untreated STZ-DM. Thus, naloxone-precipitated withdrawal in mice seems to be an appropriate model of chronic stress. Copyright (c) 2005 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16020930     DOI: 10.1159/000087034

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  7 in total

1.  Inhibitory transmission in the bed nucleus of the stria terminalis in male and female mice following morphine withdrawal.

Authors:  Brennon R Luster; Elizabeth S Cogan; Karl T Schmidt; Dipanwita Pati; Melanie M Pina; Kedar Dange; Zoé A McElligott
Journal:  Addict Biol       Date:  2019-04-09       Impact factor: 4.280

2.  The role of sigma-1 receptor and brain-derived neurotrophic factor in the development of diabetes and comorbid depression in streptozotocin-induced diabetic rats.

Authors:  Lilla Lenart; Judit Hodrea; Adam Hosszu; Sandor Koszegi; Dora Zelena; Dora Balogh; Edgar Szkibinszkij; Apor Veres-Szekely; Laszlo Wagner; Adam Vannay; Attila J Szabo; Andrea Fekete
Journal:  Psychopharmacology (Berl)       Date:  2016-01-26       Impact factor: 4.530

3.  The effect of AM281, a cannabinoid antagonist, on memory performance during spontaneous morphine withdrawal in mice.

Authors:  G Vaseghi; M Rabbani; V Hajhashemi
Journal:  Res Pharm Sci       Date:  2013-01

4.  Effect of repeated morphine withdrawal on spatial learning, memory and serum cortisol level in mice.

Authors:  Mahdieh Matinfar; Mahsa Masjedi Esfahani; Neda Aslany; Seyyed Hamid Davoodi; Pouya Parsaei; Ghasem Zarei; Parham Reisi
Journal:  Adv Biomed Res       Date:  2013-10-30

5.  The effect of nimodipine on memory loss following naloxone-induced morphine withdrawal in object recognition.

Authors:  G Vaseghi; V Hajhashemi; M Rabbani
Journal:  Res Pharm Sci       Date:  2014 Nov-Dec

6.  The Adrenal Gland Volume Measurements in Manifestation of the Metabolic Status in Type-2 Diabetes Mellitus Patients.

Authors:  Ismail Serifoglu; Ibrahim Ilker Oz; Muammer Bilici
Journal:  Int J Endocrinol       Date:  2016-08-02       Impact factor: 3.257

7.  A novel herbal treatment reduces depressive-like behaviors and increases brain-derived neurotrophic factor levels in the brain of type 2 diabetic rats.

Authors:  Chun Luo; Yuting Ke; Yanyan Yuan; Ming Zhao; Fuyan Wang; Yisheng Zhang; Shizhong Bu
Journal:  Neuropsychiatr Dis Treat       Date:  2016-11-29       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.